"Its reasonable to assume that as access becomes easier, more children will engage in unsupervised use of GLP-1RA agonists in order to facilitate reaching societal beauty standards." She added, "As the rate of mental health disorders, including eating disorders, continues to rise, healthcare providers should be screening for, and intervening on, inappropriate use of these medications. Researchers also believe children's health could be threatened, not only by the rise of counterfeit drugs that have been well documented, but also by illegitimate access to them through the internet
doi:10.1007/s00125-004-1342-6 Grant SF, Thorleifsson G, Reynisdottir I, et al
Compounded semaglutide medications are not FDA approved
Closing remarks Incretin-based AOM are currently in the spotlight as the most efficacious weight loss treatment to date 113 , exhibiting also beneficial effects on the complications of excess adiposity such as T2D, cardiovascular disease, heart failure, MASLD, OSA and possibly others